Jane Street’s Health Catalyst HCAT Stock Holding History

Jane Street’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-29,100	Closed	-$37K	–	12183
2026 Q1	$37K	Buy	+29,100	New	+$54.7K	﹤0.01%	11068
2024 Q2	–	Sell	-32,500	Closed	-$245K	–	9708
2024 Q1	$245K	Hold	32,500	–	–	﹤0.01%	7874
2023 Q4	$301K	Hold	32,500	–	–	﹤0.01%	7595
2023 Q3	$329K	Sell	32,500 -12,500	-28%	-$149K	﹤0.01%	6929
2023 Q2	$563K	Hold	45,000	–	–	﹤0.01%	6132
2023 Q1	$525K	Sell	45,000 -99,900	-69%	-$1.27M	﹤0.01%	6242
2022 Q4	$1.54M	Sell	144,900 -100	-0.1%	-$965	﹤0.01%	4277
2022 Q3	$1.41M	Buy	145,000 +120,000	+480%	+$1.59M	﹤0.01%	4808
2022 Q2	$362K	Hold	25,000	–	–	﹤0.01%	7289
2022 Q1	$653K	Hold	25,000	–	–	﹤0.01%	6987
2021 Q4	$991K	Buy	25,000 +16,400	+191%	+$747K	﹤0.01%	5924
2021 Q3	$430K	Buy	8,600 +700	+9%	+$38.2K	﹤0.01%	7566
2021 Q2	$439K	Sell	7,900 -82,400	-91%	-$4.39M	﹤0.01%	7484
2021 Q1	$4.22M	Buy	+90,300	New	+$4.37M	﹤0.01%	2656

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

CDC Financial Chicago, Illinois $239M AUM

PVM

Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HWM

HighMark Wealth Management St. Paul, Minnesota $299M AUM 53.01% 1-Year Est. Return

Jane Street's HCAT Position: Q2 2026 in Review

Jane Street increased its Health Catalyst (HCAT) stake by 3,806% in Q2 2026, buying an estimated $1.46M and bringing the position to 1,037,782 shares worth $2.07M. The position accounts for ﹤0.01% of the portfolio, ranked #5112.

Jane Street first reported a position in HCAT in Q1 2021 and has held it in 19 quarters since. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

Jane Street held 1,037,782 shares of Health Catalyst worth $2.07M as of Q2 2026.
Jane Street bought 1,011,214 Health Catalyst shares in Q2 2026, an estimated $1.46M.
Health Catalyst made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #5112 holding.
Jane Street first reported a position in Health Catalyst in Q1 2021 and has held it in 19 quarters since.
127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.